A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...

A McGill University study of more than 450,000 patients found that incretin-based Type 2 diabetes drugs, including GLP-1 ...

As the biopharma industry heads into 2026, insights gained over the past year are set to be applied and scaled, especially in ...

Background Both host and microbe metabolism of tryptophan (Trp) is altered in diabetes; however, the molecular mechanisms are ...

One of the biggest risk factors for prediabetes is weight gain. Over the past several decades, rates of obesity have risen ...

UC Riverside led mouse study finds microplastics affect male and female offspring differently. Researchers at the, Riverside ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

Long-term MACE and mortality rates are comparable between patients with and without diabetes following IVL-assisted percutaneous coronary intervention.

When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...

Sodium-glucose cotransporter 2 inhibitors (eg, dapagliflozin) are understudied in kidney transplant recipients. A trial attempted to fill this knowledge gap.